Highlights Sinopharm Group Co. Ltd.

Equities

1099

CNE100000FN7

Market Closed - Hong Kong S.E. Other stock markets 04:08:27 2024-07-12 am EDT			5-day change	1st Jan Change
19.86 ^HKD	+0.30%		-2.89%	-2.89%

Jul. 10	China Accepts Application for Sinopharm Unit's HPV Vaccine	MT
Jun. 10	Sinopharm Group Withdraws Resolution to Appoint PwC as Auditors	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ex-dividend day for final dividend	Jun. 16	FA
Sinopharm Group Co. Ltd. Declares Final Dividend for the Fiscal Year Ended December 31, 2023, Payable on 13 August 2024	Jun. 13	CI
Sinopharm Group Withdraws Resolution to Appoint PwC as Auditors	Jun. 10	MT
BPH Global to Source Bird's Nest Products from China's Sinopharm; Shares Plummet 40%	Jun. 05	MT
China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status	May. 14	MT
Wall Street Cues, Property Outlooks Lift Asian Stock Markets	Apr. 29	MT
China, Hong Kong stocks rise, led by property shares	Apr. 29	RE
Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Sinopharm Group Shares Fall as Higher Costs Cut Into Quarterly Profit	Apr. 28	DJ
Sinopharm Group's Q1 Profit Falls as Operating Costs Rise	Apr. 28	MT
Central Bank, Tech Outlooks Lift Major Asian Stock Markets	Apr. 26	MT
Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets	Apr. 16	MT
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator	Mar. 27	MT
Sinopharm's Attributable Profit Jumps in 2023 on Higher Revenue	Mar. 24	MT
Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024	Mar. 24	CI
Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 24	CI
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	Mar. 21	MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	Mar. 21	MT
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer	Feb. 22	MT
Sinopharm offers to take China-TCM private in nearly $3 bln deal	Feb. 21	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sinopharm Group Co. Ltd.

Equities

1099

CNE100000FN7

Highlights

Filters